Pharmaceutical Executive June 4, 2024
BD announced that it will pay cash to acquire the advanced monitoring solutions company.
Medical technology company Becton, Dickinson, and Company (BD) announced that it will acquire Edwards Lifesciences’ Critical Care Product Group for $4.2 billion in cash. According to a press release,1 BD acquired the advanced monitoring solutions company in order to expand its own smart connected care solutions.
The acquisition is expected to close by the end of 2024. In order to fund it, BD will use about $1 billion of its own cash and take on $3.2 billion of new debt. Within a year to a year-and-a-half from closing, BD plans on significantly reducing its debt load by deploying free cash flows towards repayment.
In a press...